The Spondyloarthritis Research Consortium of Cananda (SPARCC) is a transdiscliplinary research network of investigators interested in spondyloarthritis. The group has been supported by a new research initiative by The Arthritis Society. SPARCC aims to address the genetic basis of susceptibility of the disease and develop and validate clinical and imaging outcomes to assess disease activity and structural damage over time, the response to therapy, and the clinical burden of illness in terms of quality of life and disability. The first step was to develop a database that would allow ascertainment of phenotype for genetic studies, as well as accurate and detailed longitudinal information for disease expression and outcome studies. This article describes the SPARCC database and outlines difficulties and possible solutions for maintaining such a database. The Journal of Rheumatology Copyright © 2011. All rights reserved.
CITATION STYLE
Gladman, D. D., Rahman, P., Cook, R. J., Shen, H., Zummer, M., Thomson, G., … Maksymowych, W. P. (2011). The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritis. Journal of Rheumatology, 38(7), 1343–1348. https://doi.org/10.3899/jrheum.101102
Mendeley helps you to discover research relevant for your work.